Literature DB >> 18571022

Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.

Raúl González-García1, Luis Naval-Gías, Francisco J Rodríguez-Campo, Jesús Sastre-Pérez, Mario F Muñoz-Guerra, José L Gil-Díez Usandizaga.   

Abstract

PURPOSE: In relation to primary squamous cell carcinoma (SCC) of the oral cavity, many clinical and histopathologic factors have been reported to be predictive for lymph neck node relapse. However, few large studies concerning the association between clinical-histopathologic features and the development of contralateral lymph neck node relapse (CLNR) after surgical resection of primary SCC of the oral cavity are available. The purpose of this study was to analyze those factors related to the appearance of contralateral lymph neck node relapse in patients with SCC of the oral cavity primarily treated by means of surgery. PATIENTS AND METHODS: This study was based on a series of 315 consecutive patients with primary SCC of the oral cavity treated between June 1979 and December 1999. All patients were treated primarily by means of surgery with or without adjuvant radiotherapy. The following data were analyzed for each patient: age, gender, habits, time to diagnosis, performance status, tumor clinical features, histologic grade, TNM staging, type of neck dissection, survival outcome, and functional/esthetic results at the end of the follow-up period. Histologic study included the pTNM classification, tumor size, surgical margins, extracapsular spread of lymph neck node metastasis, perineural infiltration, peritumoral inflammation, and bone involvement.
RESULTS: Eighty-three patients eventually died of the disease (26.34%). A total of 177 patients were alive with no evidence of recurrence at the end of the study. The mean disease-specific survival rate was 147 +/- 6 months. Twenty-nine (9.1%) patients developed ipsilateral lymph neck node relapse (ILNR), whereas 18 (5.69%) patients developed CLNR. The mean period of time from surgery to the appearance of CLNR was 12.52 months (range, 3 to 49 months). Eighteen of 29 patients with ILNR finally died of the disease. Seven of 18 patients with CLNR died of the disease. Several clinical-pathologic features were predictive for CLNR in SCC of the oral cavity, such as the time to diagnosis, TNM staging, positive ipsilateral clinical N status, histopathologic differentiation, surgical margins of primary tumor resection, type of neck dissection, and perineural infiltration.
CONCLUSION: Delay in diagnosis 12 or more months is associated with increased CLNR. Clinical and pathologic factors predictive for CLNR are TNM tumor staging IV, histopathologic poor-differentiation of the primary tumor, surgical margins less than 1 cm around the primary tumor, performance of isolated ipsilateral modified type III radical neck dissection, and perineural tumor involvement. Presence of ipsilateral neck metastasis at the time of diagnosis is associated with an augmented incidence of CLNR in SCC of the oral cavity.

Entities:  

Mesh:

Year:  2008        PMID: 18571022     DOI: 10.1016/j.joms.2008.01.012

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  10 in total

1.  Skp2 Regulates the Expression of MMP-2 and MMP-9, and Enhances the Invasion Potential of Oral Squamous Cell Carcinoma.

Authors:  Shin-Ichi Yamada; Souichi Yanamoto; Tomofumi Naruse; Yuki Matsushita; Hidenori Takahashi; Masahiro Umeda; Takayuki K Nemoto; Hiroshi Kurita
Journal:  Pathol Oncol Res       Date:  2016-02-13       Impact factor: 3.201

2.  Concomitant radio- and fluorescence-guided sentinel lymph node biopsy in squamous cell carcinoma of the oral cavity using ICG-(99m)Tc-nanocolloid.

Authors:  Nynke S van den Berg; Oscar R Brouwer; W Martin C Klop; Bariş Karakullukcu; Charlotte L Zuur; I Bing Tan; Alfons J M Balm; Michiel W M van den Brekel; Renato A Valdés Olmos; Fijs W B van Leeuwen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-04-18       Impact factor: 9.236

3.  FOXC2 expression is associated with tumor proliferation and invasion potential in oral tongue squamous cell carcinoma.

Authors:  Naomi Imayama; Shin-Ichi Yamada; Souichi Yanamoto; Tomofumi Naruse; Yuki Matsushita; Hidenori Takahashi; Sachiko Seki; Shuichi Fujita; Tohru Ikeda; Masahiro Umeda
Journal:  Pathol Oncol Res       Date:  2015-01-09       Impact factor: 3.201

4.  Overexpression of cortactin increases invasion potential in oral squamous cell carcinoma.

Authors:  Shin-ichi Yamada; Souichi Yanamoto; Goro Kawasaki; Akio Mizuno; Takayuki K Nemoto
Journal:  Pathol Oncol Res       Date:  2010-01-13       Impact factor: 3.201

5.  Occurrence of contralateral lymph neck node metastasis in patients with squamous cell carcinoma of the oral cavity.

Authors:  Liziane C Donaduzzi; Ferdinando De-Conto; Luana S Kuze; Gisele Rovani; Mateus E Flores; Adriano Pasqualotti
Journal:  J Clin Exp Dent       Date:  2014-06-01

Review 6.  Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma.

Authors:  Tomonori Sasahira; Tadaaki Kirita
Journal:  Int J Mol Sci       Date:  2018-08-16       Impact factor: 5.923

7.  Fructose-1,6-Bisphosphatase 2 Inhibits Oral Squamous Cell Carcinoma Tumorigenesis and Glucose Metabolism via Downregulation of c-Myc.

Authors:  Liang Wang; Jinbing Wang; Yi Shen; Zhiwei Zheng; Jian Sun
Journal:  Oxid Med Cell Longev       Date:  2022-05-06       Impact factor: 6.543

8.  Treatment and Prognosis of Oral Cancer Patients with Confirmed Contralateral Neck Metastasis: A Multicenter Retrospective Analysis.

Authors:  Yuki Sakamoto; Mitsunobu Otsuru; Takumi Hasegawa; Masaya Akashi; Shin-Ichi Yamada; Hiroshi Kurita; Masaya Okura; Nobuhiro Yamakawa; Tadaaki Kirita; Souichi Yanamoto; Masahiro Umeda; Yuka Kojima
Journal:  Int J Environ Res Public Health       Date:  2022-07-28       Impact factor: 4.614

9.  Diversity of the Origin of Cancer Stem Cells in Oral Squamous Cell Carcinoma and Its Clinical Implications.

Authors:  Chonji Fukumoto; Daisuke Uchida; Hitoshi Kawamata
Journal:  Cancers (Basel)       Date:  2022-07-22       Impact factor: 6.575

10.  Serine hydroxymethyltransferase 2 (SHMT2) potentiates the aggressive process of oral squamous cell carcinoma by binding to interleukin enhancer-binding factor 2 (ILF2).

Authors:  Hui Zhang; Yilei Che; Bin Xuan; Xiaozhen Wu; Hui Li
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.